1. Introduction {#sec0005}
===============

Brain states vary from moment to moment throughout the day. Humans typically cycle between three major behavioral states: wakefulness, rapid eye movement (REM) sleep and non-REM (NREM) sleep, with additional stages of NREM sleep. REM and NREM sleep have distinct characteristics. For example, NREM sleep is characterized by slow, large-amplitude fluctuations of cortical electroencephalograms (EEGs) whereas REM sleep is characterized by fast, small-amplitude fluctuations of EEGs. Although these sleep states are closely related with each other with respect to neural mechanisms and functions ([@bib0170]; [@bib0465]; [@bib0885]; [@bib1110]; [@bib1205]; [@bib1370]), this review article particularly focuses on the mechanisms underlying REM sleep.

REM sleep is associated with vivid dreaming, rapid eye movement, muscle atonia and other body homeostatic signatures. Electrophysiological characteristics of REM sleep include desynchronized cortical EEG, hippocampal theta waves and ponto-geniculo-occipital (PGO) waves ([@bib0055]; [@bib0170]; [@bib0295]; [@bib0545]; [@bib0710]; [@bib0900]; [@bib1110]; [@bib1370]; [@bib0180]; [@bib0270]). REM sleep is also known as "paradoxical sleep" because the desynchronized EEG observed during REM sleep resembles that during wakefulness, but without muscle tone ([@bib0560]). REM sleep also contains phasic and tonic periods: phasic periods are characterized by bursts of rapid eye movements whereas no rapid eye movements occur during tonic periods ([@bib1390]; [@bib0850]). Although detailed characteristics (e.g., REM sleep duration, eye movements) vary across species, birds and lizards also exhibit similar electrophysiological features of REM sleep, suggesting that REM sleep evolved in a common ancestor early in amniote evolution ([@bib0655]; [@bib0825]; [@bib1155]; [@bib0520]; [@bib1140]).

The sleep stage with REM and desynchronized EEG activity was originally discovered in humans in the 1950s ([@bib0055]; [@bib0295]), and subsequently confirmed in cats ([@bib0290]). Jouvet et al. comprehensively described the main characteristics of REM sleep and established the notion that the pons is responsible for REM sleep ([@bib0545]; [@bib0555]).

Since these landmark studies, with the advent of technological advancements, our understanding of the neurobiology underlying REM sleep regulation has expanded considerably. In the late 1950s and 60s, lesion, electrophysiological and pharmacological experiments identified the brainstem structures and neurotransmitters responsible for REM sleep ([@bib0545]). In the 70s, unit recording experiments identified brainstem neurons which are exclusively active (REM-on) or silent (REM-off) during REM sleep in cats ([@bib0765]; [@bib0470]; [@bib0550]). Subsequently, as novel approaches ranging from Fos mapping and juxtacellular recording to recent genetic and molecular technologies have been adopted, various hypothalamic and brainstem nuclei have been identified to contribute to REM sleep ([@bib0110]; [@bib0435]; [@bib0595]; [@bib0685]; [@bib0725]; [@bib1110]; [@bib1375]; [@bib1370]; [@bib0170]).

Trends in choice of animal models have also changed ([Fig. 1](#fig0005){ref-type="fig"}): Although the cat model initially dominated the field, the use of rats had become increasingly popular until the 2000s. This is probably due to their smaller size and the development of anatomical, histochemical and electrophysiological methods. Over the past decade, the use of mice has rapidly gained momentum due to the revolution of molecular genetic approaches for systems-level studies, such as viral tracing, optogenetics and chemogenetics. While there is no doubt that mice will soon become a dominant species in this field, it should be also noted that REM sleep has been confirmed in different species including the *Pogona* dragons ([@bib1140]), indicating the importance of comparative studies.Fig. 1**Publication records on REM sleep research**. The number of publication records on REM sleep was extracted from the PubMed database for each animal species. The publication records of computational studies on sleep-wake cycle were also extracted ('model').Fig. 1

In addition to animal studies, computational/mathematical studies of sleep-wake cycles have also made important contributions to this field since the pioneering studies by [@bib0770] and [@bib0130]. Given the complexity of sleep regulatory circuits, such quantitative approaches will become increasingly essential. Indeed, there has been an upward trend of publication records over the past two decades ([Fig. 1](#fig0005){ref-type="fig"}).

In the present review, we summarize the current status of our understanding of REM sleep regulation, with a focus on the circuit mechanisms and computational models. First, we summarize the current understanding of key brain regions and neuropeptides within REM sleep-regulating circuits. Second, we cover a range of computational models to explain the sleep-wake cycle. Finally, we discuss outstanding issues and future challenges in this field. Readers should also refer to other review articles ([@bib0170]; [@bib0715]; [@bib0900]; [@bib1085]; [@bib1110]; [@bib1370]).

2. REM sleep-regulating circuits {#sec0010}
================================

REM sleep-regulating circuits are widespread throughout the brainstem (midbrain, pons, and medulla) and the hypothalamus and involve a range of neurotransmitters and neuropeptides. In this section, we survey the literature on key components of REM sleep-regulating circuits within the brainstem and hypothalamus ([Fig. 2](#fig0010){ref-type="fig"}).Fig. 2**Diagram of REM sleep-regulating circuits.** Brainstem and hypothalamic areas described in the main text are shown, with a simplified view of activity during REM sleep as well as connectivity. DMH, dorsomedial hypothalamus; DpMe, dorsal part of the deep mesencephalic reticular nuclei; DRN, dorsal raphe nucleus; eVLPO, extended area of the ventrolateral preoptic area; GiA, alpha gigantocellular nucleus; GiV, ventral gigantocellular nucleus; LC, locus coeruleus; LDT, laterodorsal tegmental nucleus; LPGi, lateral paragigantocellular nucleus; MCH, melanin concentrating hormone neurons; OH, orexin/hypocretin neurons; PPT, pedunculopontine tegmental nucleus; RMg, raphe magnus; RPA, nucleus raphe pallidus; SLD, sublaterodorsal nucleus; vlPAG, ventrolateral periaqueductal gray. Glu, glutamate; ACh, acetylcholine; GABA, γ-aminobutyric acid; Gly, glycine.Fig. 2

2.1. Brainstem REM sleep-regulating circuits {#sec0015}
--------------------------------------------

Research on brainstem REM sleep-regulating circuits has a long history since pioneering studies by Jouvet and his colleagues ([@bib0555]; [@bib0545]). Despite numerous efforts over the past six decades, a comprehensive picture of brainstem REM sleep-regulating circuits is still lacking. Here we focus on the key brainstem nuclei involved in REM sleep regulation, by summarizing their 1) anatomical features, 2) neural activity during REM sleep and 3) gain- and loss-of-function studies.

### 2.1.1. Sublaterodorsal nucleus {#sec0020}

The sublaterodorsal (tegmental) nucleus (SLD) in rodents has long been implicated in REM sleep genesis and muscle atonia ([@bib0700], [@bib0710]; [@bib0725]; [@bib1110]).

***Anatomy.*** The SLD is located immediately ventral from the periaqueductal gray (PAG) and corresponds to the rostral part of the subcoeruleus nucleus. It is equivalent to the peri-locus coeruleus alpha (peri-LCα) in the cat ([@bib1050], [@bib1055]) and is composed of glutamatergic, GABAergic and cholinergic neurons ([@bib1055]; [@bib0110]).

The SLD receives glutamatergic inputs from the lateral and ventrolateral PAG (vlPAG), the primary motor cortex, the bed nucleus of the stria terminalis (BNST) and the central nucleus of the amygdala. It also receives GABAergic inputs from the mesencephalic, pontine reticular nuclei and to a lesser extent the parvicellular reticular nucleus and contralateral SLD ([@bib0115]; [@bib0685]). Although a recent study with a cell-type-specific tracing approach confirmed the projection from vlPAG GABAergic neurons onto glutamatergic neurons in the SLD ([@bib1380]), input specificity onto each SLD cell-type remains to be fully characterized.

SLD glutamatergic neurons project rostrally to the intralaminar nuclei of the thalamus, posterior hypothalamus, and basal forebrain (BF), and caudally to glycinergic neurons in the raphe magnus (RMg), ventral and alpha gigantocellular nuclei (GiA and GiV) and the lateral paragigantocellular nucleus (LPGi). These rostral and caudal projections are thought to be responsible for cortical desynchronization and muscle atonia, respectively ([@bib1050]; [@bib0525]; [@bib0110]).

***Activity.*** SLD glutamatergic neurons are primarily REM-on, meaning that they are more active during REM sleep compared to non-REM (NREM) sleep and wakefulness ([@bib1020]; [@bib1040]; [@bib0685]; [@bib0215]). It has been repeatedly shown that SLD glutamatergic neurons strongly express Fos after prolonged REM sleep in rats and mice ([@bib0215]; [@bib0595]). Although SLD GABAergic neurons have been initially reported to be REM-on ([@bib0685]), a subsequent report does not support this observation ([@bib1090]). SLD cholinergic neurons do not appear to be REM-on based on Fos mapping ([@bib1340]) although an extracellular recording study demonstrated that a subpopulation of SLD cholinergic neurons are active during both REM sleep and wakefulness ([@bib1030]). Thus, although the SLD has been implicated in REM sleep genesis, future studies need to reconcile the heterogeneity of state-dependent and cell-type-specific firing within the SLD.

***Function.*** Pharmacologically GABAa antagonists (bicuculine or gabazine) and glutamate agonist can induce REM sleep ([@bib0110]; [@bib1410]; [@bib0880]), suggesting that tonic glutamatergic barrage and the removal of a tonic GABAergic tone can cause REM sleep. In contrast, cholinergic agonist (carbachol) induces REM when injected into the cat peri-LCα, but not in all cases when applied to the rat SLD ([@bib0110]; [@bib0145]; [@bib0300]; [@bib0375]; [@bib1145]; [@bib1330]). Given the contradictory results of cholinergic effects on REM sleep induction, further studies are necessary to quantitatively determine how the balance between different transmitter inputs onto SLD neurons can contribute to REM sleep induction.

Furthermore, a recent chemogenetic study demonstrated that glutamatergic neurons in the rostrolateral SLD ("Atoh1-E10.5-medial cells") promote NREM sleep and inhibit REM sleep ([@bib0445]). These glutamatergic neurons project to GABAergic neurons in the deep mesencephalic reticular nucleus (DpMe), which negatively regulate REM sleep, possibly inhibiting REM sleep-promoting neurons in the SLD. Therefore, REM sleep-regulating circuitry within the SLD is more complex than previously appreciated.

The SLD also plays a causal role in muscle atonia. A focal lesion of the SLD or the deletion of glutamate signaling induces a REM sleep-like state, but without muscle atonia, thus implicating aberrant glutamatergic transmission in REM sleep behavioral disorder ([@bib0595]; [@bib0685]). A prominent explanatory mechanism of muscle atonia is that because SLD glutamatergic neurons project to glycinergic/GABAergic neurons in the ventral medulla (vM), which in turn inhibit spinal motor neurons, the removal of SLD excitatory inputs onto vM cannot induce muscle atonia ([@bib0110]; [@bib0725]; [@bib0685]). However, as we discuss below, distinct vM circuits have been implicated in REM sleep regulation and muscle atonia. Therefore, detailed circuit analysis between the SLD and vM is still required. Furthermore, the role of SLD GABAergic neurons is also unclear.

### 2.1.2. Ventrolateral periaqueductal gray and deep mesencephalic reticular nucleus {#sec0025}

The ventrolateral periaqueductal gray (vlPAG) together with the adjacent dorsal part of the deep mesencephalic reticular nucleus (DpMe) has been implicated in gating REM sleep by receiving inputs from the hypothalamus and other brainstem structures ([@bib0715]; [@bib0905]).

***Anatomy.*** The vlPAG is a part of the large midbrain structure, the PAG, and is located ventrolaterally within the caudal section of the PAG. vlPAG neurons are composed of glutamatergic, GABAergic and dopaminergic (DA) neurons. vlPAG DA neurons are often referred as to the dorso-caudal extension of the A10 group, which includes DA neurons in the dorsal raphe nucleus (DRN) ([@bib0205]; [@bib0310]; [@bib0475]).

The vlPAG is an anatomical hub of REM sleep regulatory circuits within the brainstem. vlPAG neurons receive inputs from the forebrain, hypothalamus and brainstem, such as the central nucleus of amygdala, the zona incertia (ZI), the nucleus accumbens, the lateral hypothalamus, the lamina terminalis including the median preoptic nucleus (MnPO), the extended part of the ventrolateral preoptic nucleus (eVLPO), SLD, peduncluopontine tegmental nucleus/laterodorsal tegmental nucleus (PPT/LDT), and the vM ([@bib0115]; [@bib0175]; [@bib0220]; [@bib0500]; [@bib0645]; [@bib1295], [@bib1300]; [@bib1375]; [@bib1445]; [@bib0685]).

Both GABAergic and non-GABAergic vlPAG neurons project to the SLD ([@bib0115]; [@bib1380]) while GABAergic neurons also strongly innervate the DRN ([@bib0365]) and the locus coeruleus (LC) ([@bib1380]). DA neurons have reciprocal connections with the medial prefrontal cortex, ventrolateral preoptic nucleus (VLPO), orexin/hypocretin neurons, LDT cholinergic neurons, and LC noradrenergic neurons ([@bib0680]).

***Activity.*** REM-on and --off neurons are intermingled within the vlPAG and the DpMe, which reflects the complex nature of anatomical properties described above. While the majority of GABAergic neurons are REM-off, a subset of GABAergic neurons are also REM-on ([@bib0685]; [@bib1090]; [@bib1380]). REM-off neurons have been suggested to suppress SLD glutamatergic neurons during wakefulness and NREM sleep to prevent muscle atonia and REM sleep induction ([@bib0685]).

***Function.*** The functional role of vlPAG neurons in REM sleep was first suggested with a lesion study carried out by Jouvet and his colleagues ([@bib0905]). While neurotoxic lesions in the vlPAG and DpMe promote REM sleep ([@bib0685]), muscimol (GABAa agonist) application increases REM sleep in both cats ([@bib1105]) and rats ([@bib1090]). Furthermore, optogenetic activation of vlPAG GABAergic neurons suppresses REM sleep generation ([@bib1375], [@bib1380]). As described above, GABAergic neurons in the DpMe receive inputs from glutamatergic neurons located in the rostrolateral SLD. Chemogenetic activation of DpMe GABAergic neurons inhibit REM sleep and promote NREM sleep, whereas chemogenetic silencing enhances REM sleep ([@bib0445]). These results are consistent with the notion that REM-off neurons located within the vlPAG and DpMe suppress REM sleep.

The function of REM-on neurons, however, remains elusive. Optogenetic stimulation of vlPAG GABAergic neurons can inhibit REM-on GABAergic neurons ([@bib1380]), suggesting intrinsic connections between REM-on and --off GABAergic neurons ([@bib1090]; [@bib1380]). It has been proposed that REM-on GABAergic neurons in vlPAG can be activated by cholinergic inputs, resulting in the suppression of DRN serotonergic neurons ([@bib1430]). These results suggest that REM-on and REM-off GABAergic neurons in the vlPAG play antagonistic roles in REM sleep regulation.

vlPAG DA neurons are wake-promoting ([@bib0680]), but the functional role of vlPAG glutamatergic neurons remains unclear. In addition, because the vlPAG receives inputs from the amygdala ([@bib0175]) and has long been implicated in both fear-associated defensive behaviors and pain ([@bib0080]; [@bib1265]), the relationship between anxiety/fear and sleep would be an interesting topic to explore.

### 2.1.3. Ventral medulla {#sec0030}

The functional role of the ventral medulla (vM) in REM sleep and muscle atonia has been actively debated ([@bib0710], [@bib0700]; [@bib0725]; [@bib1090]; [@bib0685]; [@bib1375]). Accumulating evidence suggests that vM neurons play distinct roles in REM sleep and muscle atonia depending on circuits as summarized below.

***Anatomy.*** The vM is located within the ventrocaudal portion of the brainstem. It includes the raphe magnus (RMg), ventral and alpha gigantocellular nuclei (GiA and GiV) and the lateral paragigantocellular nucleus (LPGi), and other nuclei. GiA, GiV and RMg are located ventromedially within the vM, thus they are collectively known as the ventromedial medulla (vmM). Within the vM, diverse cell types are intermingled ([@bib0485]; [@bib0630]; [@bib0960]): while glutamatergic and GABAergic neurons are widely distributed, many GABAergic neurons are colocalized with glycine. Tyrosine hydroxylase positive neurons and a dense cluster of cholinergic neurons can be found in the LPGi and the nucleus ambiguus, respectively. Serotonergic neurons can be found in the RMg (B3 cell group) and the nucleus raphe pallidus (RPA) (B1 cell group).

The vM receives inputs from the spinal cord, medulla, pons, midbrain, hypothalamus, amygdala, and cortex ([@bib1170]; [@bib1310]; [@bib0045]). Of these, GABA/glycinergic neurons receive strong glutamatergic inputs from the SLD ([@bib0350]; [@bib0720]).

GABA and/or glycine containing neurons in the vmM strongly innervate spinal motor neurons ([@bib0490]; [@bib0495]). On the other hand, the LPGi project to the solitary tract, parabrachial nucleus, and Kӧlliker-Fuse nucleus ([@bib0405]; [@bib1170]). LPGi GABAergic neurons provide inputs to the LC ([@bib0330]; [@bib1170]). Interestingly, distinct populations of GABAergic neurons within the vM project rostrally to the vlPAG and caudally to the spinal cord ([@bib1375]) although the exact distribution of these populations within the vM remains unclear. Serotonergic cell groups (B1 and B3) in the vM also project to diverse areas, including the spinal cord, Kӧlliker-Fuse nucleus, LDT, SLD, LC, inferior colliculus, part of the thalamus, hypothalamus, BF and hippocampus ([@bib0650]). Detailed cell type-specific projections, including glutamatergic, cholinergic, and aminergic projections, remain to be explored.

***Activity.*** GiV GABAergic neurons are REM-on in both cats ([@bib1165]) and rodents ([@bib0735]; [@bib1090]). An enhanced Fos expression was observed following recovery from REM sleep deprivation in GiV, GiA and RMg GABAergic/glycinergic neurons, but to a lesser extent in the LPGi ([@bib1305]). Indeed, LPGi GABAergic neurons show diverse firing responses including REM-on, REM-off, and other types ([@bib1170]). A recent optogenetic tagging study ([@bib1375]) showed that firing rates of vM GABAergic neurons increase gradually over ∼30 s before the NREM to REM transition and abruptly decrease at the end of REM sleep. Non-GABAergic neurons, on the other hand, respond with an increase in firing ∼10 s before the onset of REM sleep and a gradual decrease at the termination of REM sleep. Many of these non-GABAergic neurons were most active during running or moving. RPA serotonergic neurons are REM-off ([@bib0455]). Thus, the composition of REM-on and --off neurons vary across nuclei and cell types within the vM.

***Function.*** The functional role of vM neurons in REM sleep induction and muscle atonia has been actively debated ([@bib0350]; [@bib0720]; [@bib1305]; [@bib1375]; [@bib0685]). For example, GiV neurons have long been implicated in muscle atonia by receiving strong glutamatergic inputs from the SLD and co-releasing GABA and glycine onto spinal motor neurons ([@bib0710]; [@bib0350]; [@bib0720]). However, lesioning the vM has had no effect on muscle atonia ([@bib0685]). Weber and his colleague ([@bib1375]) recently demonstrated the causal role of the vM in REM sleep regulation, rather than muscle atonia: optogenetic activation of vM GABAergic neurons induces and prolongs REM sleep and chemogenetics inhibition of vM GABAergic neurons reduces REM sleep quantities. Another recent study specifically targeted the vmM (GiV, GiA and RMg) to demonstrate that genetic inactivation of vmM GABAergic/glycinergic neurons does not affect sleep architecture including REM sleep, but suppresses muscle atonia ([@bib1305]). Thus, if the optogenetic/chemogenetic study ([@bib1375]) primarily targeted the LPGi, rather than the vmM, it is probable that vmM and LPGi inhibitory neurons may play distinct roles in muscle atonia and REM sleep, respectively. Further investigation to reconcile these observations is required.

### 2.1.4. Pedunculopontine tegmental nucleus and laterodorsal tegmental nucleus {#sec0035}

The pedunculopontine tegmental nucleus (PPT) and laterodorsal tegmental nucleus (LTD) are a brainstem cholinergic system and have long been implicated in REM sleep, arousal and cortical desynchronization ([@bib0760]; [@bib0795]; [@bib1110]; [@bib1370]). Although pontine cholinergic neurons were originally thought to play a causal role in REM sleep induction, the exact role of the PPT/LDT in REM sleep remains to be determined fully ([@bib0390]; [@bib0385]; [@bib0600]; [@bib1320]).

***Anatomy.*** The PPT and LDT are located within the caudal cholinergic column (Ch5 and Ch6) and contain a heterogeneous population of cholinergic, glutamatergic and GABAergic neurons ([@bib0225]; [@bib1360]; [@bib0345]). Subpopulations of these cell classes expressed calcium-binding proteins (calbindin, calretinin, and parvalbumin) and they are heterogeneously distributed within the PPT ([@bib0750]).

The PPT/LDT receives inputs from diverse areas of the brain, including the cortex, thalamus, hypothalamus, pons, cerebellum, medulla, spinal cord and the basal ganglia ([@bib1125]; [@bib1075]; [@bib0745]). Within the brainstem, DRN and LC neurons project to the PPT ([@bib0535]; [@bib1350]), with preferential projection from DRN serotonergic neurons to non-cholinergic neurons ([@bib1190]).

Both cholinergic and non-cholinergic axonal projections have been traced at the single cell resolution ([@bib0745]; [@bib0795]; [@bib0800]). Outputs include, but are not limited to the thalamus, basal ganglia, BF, hypothalamus, LC, pontine reticular formation, ventral tegmental area (VTA), SLD and DRN ([@bib0235]; [@bib0345]; [@bib0695]; [@bib0745]; [@bib0795]; [@bib1130]). Interestingly, the topographical organization of ascending cholinergic innervation was also described ([@bib0795]): rostral PPT cholinergic neurons preferentially innervate motor-related areas, such as the basal ganglia, whereas LDT cholinergic neurons preferentially innervate limbic-related areas, such as the VTA.

***Activity.*** Different cell types show distinct state-dependent firing patterns: cholinergic neurons are most active during wakefulness and REM sleep, whereas glutamatergic and GABAergic neurons appear to be maximally active either during wake, REM sleep or during both wake and REM ([@bib0275]; [@bib1195]; [@bib0325]; [@bib0245]; [@bib0140]; [@bib0765]). Consistent with these findings, Fos mapping studies have also shown that both cholinergic and GABAergic neurons are active during REM sleep in both cats and rats ([@bib1340]; [@bib0730]; [@bib1260]).

***Function.*** There is an ongoing debate on the functional role of the PPT/LDT in the initiation and maintenance of REM sleep. Lesion ([@bib0910]; [@bib1150]; [@bib1385]; [@bib1100]) and pharmacological ([@bib0110]; [@bib0375]; [@bib0300]; [@bib0360]; [@bib0040]; [@bib0070]; [@bib0230]; [@bib0950]) studies have provided inconsistent and contradictory results. Recently, chemogenetic activation of PPT neurons was performed ([@bib0600]): glutamatergic activation increases the duration of wakefulness, while GABAergic activation moderately reduces the duration of REM sleep. Consistent with pharmacological studies ([@bib0110]; [@bib0395]), chemogenetic activation of cholinergic neurons has no effect on REM sleep, but promotes light NREM sleep. On the other hand, electrical stimulation of LDT neurons increases the number of REM sleep bouts ([@bib1245]). Similarly, optogenetic activation of PPT/LDT cholinergic neurons during NREM sleep promotes REM sleep ([@bib1320]). While the current consensus is that PPT/LDT neurons play a modulatory role in REM sleep generation ([@bib0390]), state-dependent coordination of PPT/LDT neuronal firing and its influence on downstream nuclei (e.g., SLD and vlPAG) and REM sleep induction need to be fully explored.

### 2.1.5. Locus coeruleus {#sec0040}

Norepinephrine (NE)-producing neurons are located across brainstem nuclei with diverse populations projecting to numerous regions. Of particular interest is the LC, which is one of the most intensively investigated brainstem nuclei in terms of developmental origin, molecular profiles, anatomical connectivity, and physiological and pathophysiological functions ([@bib0065]; [@bib0985]; [@bib1115]).

***Anatomy.*** The LC is located in the dorsal region of the caudal pons, lateral to the LDT and dorsal to the caudal part of the SLD in mice. All LC neurons produce NE by converting from DA using dopamine-beta-hydroxylase (Dbh). Neuropeptide galanin is also expressed in the majority (up to 80%) of LC neurons ([@bib0480]; [@bib0985]). Two morphological classes of LC neurons, multipolar and fusiform cells, have been described in the rat ([@bib0400]; [@bib1210]). Thus, although all LC neurons are NE-producing, they are not necessarily homogeneous.

LC neurons receive inputs from other arousal systems and project widely throughout the CNS ([@bib0570]; [@bib0695]; [@bib1115]; [@bib1120]). Recently, the anatomical input-output relationship of LC-NE neurons was comprehensively characterized by using advanced viral tracing approaches ([@bib1120]). LC-NE neurons projecting to diverse brain regions receive inputs from similar areas. Thus, they integrate information from, and broadcasts to, many brain regions. However, there is also specificity. For example, medulla-projecting LC-NE neurons receive disproportionally smaller input from the central amygdala than other LC-NE neurons. Although LC neurons were previously thought to be the only source of NE projections to the cortex, NE neurons from other brainstem nuclei also project to the cortex ([@bib0985]). In the context of REM sleep regulation, LC-NE neurons receive strong GABAergic inputs from the vlPAG, and both the dorsal and lateral paragigantocellular nuclei (DPGi and LPGi), which contain REM-on neurons ([@bib0365]; [@bib0725]; [@bib1345]).

***Activity and function***. LC neurons are generally REM-off ([@bib0025]; [@bib0060]; [@bib0470]; [@bib0780]). Thus, they promote arousal and play an antagonistic role in REM sleep. While LC-NE activity correlates with pupil diameter during wakefulness ([@bib0065]), LC-NE neurons are virtually silent during REM sleep. Indeed, the pupil size during REM sleep is minimum ([@bib1440]).

NE inhibits PPT/LDT cholinergic neurons ([@bib0690]; [@bib1400]) and pharmacological enhancement of NE transmission suppresses REM sleep ([@bib0370]; [@bib0530]; [@bib0540]). However, optogenetic inhibition of LC neurons did not alter REM sleep ([@bib0185]). These conflicting observations may be reconciled in the future by characterizing the remaining NE containing brainstem nuclei (i.e., A1, A2, A5, A7, LC and subcoeruleus). Indeed, a moderate number of NE neurons (A1 and A2) displayed Fos expression after the recovery of REM deprivation, suggesting that non-LC NE neurons may be important for REM sleep regulation ([@bib0630]). Thus, in addition to detailed anatomical study across these nuclei, the exact role of brainstem NE neurons in REM sleep regulation still need to be fully characterized.

### 2.1.6. Dorsal raphe nucleus {#sec0045}

Serotonergic (5-HT) neurons can be found in the raphe nuclei, of which the dorsal raphe nucleus (DRN) (B5 cell group) is the largest serotonergic nucleus ([@bib0265]; [@bib0510]). The role of serotonin in sleep was originally proposed by Jouvet ([@bib0550]). However, it has since been shown that DRN serotonergic neurons are wake-promoting and suppress REM sleep, similar to LC-NE neurons ([@bib0780]; [@bib1275]). Nevertheless, because of the diversity of cell types within the DRN as well as serotonin receptors across brain regions, the role of serotonin in sleep remains elusive.

***Anatomy.*** The DRN is located in the midline of the brainstem, ventral to the cerebral aqueduct, occupying the ventral part of the PAG. The DRN neurons are composed of serotonergic, glutamatergic and GABAergic neurons, many of which also express a variety of neuropeptides, such as galanin and substance P ([@bib0835]). A subset of serotonergic neurons also co-release glutamate ([@bib0340]). There is a small population of DA neurons in the DRN ([@bib0205]; [@bib0310]; [@bib0475]).

The DRN receives GABAergic inputs from multiple regions, such as the BF, hypothalamus, substantia nigra, VTA, ventral PAG, rostral pontine reticular nucleus, and dorsal gigantocellular nucleus ([@bib0365]; [@bib0705]). DRN neurons also receive inputs from neurons releasing a variety of neurotransmitters and neuropeptides, such as histamine, DA, NE, ACh, orexin/hypocretin and melanin-concentrating hormone (MCH) ([@bib0890]; [@bib1045]; [@bib0075]; [@bib1015]; [@bib1405]; [@bib0620]; [@bib0450]; [@bib0575]).

DRN neurons innervate a wide range of areas, including the cerebral cortex, amygdala, BF, thalamus, preoptic and hypothalamic areas, LC, and pontine reticular formation ([@bib0505]; [@bib0915]). Based on the distribution of cell types and anatomical projections, six subdivisions of the DRN have been proposed in rats ([@bib0660]; [@bib0835]).

***Activity.*** Although the majority of 5-HT neurons are active during wake and virtually inactive during REM sleep ([@bib0780]; [@bib1275]), heterogeneity of their firing has been reported in cats, rats and mice ([@bib0035]; [@bib0420]; [@bib1035]; [@bib1290]; [@bib1025]). For example, a fourth of the DRN neurons are sleep-active and around one-fifth are active during both wakefulness and REM sleep in mice. They are topographically organized ([@bib1025]). DRN-DA neurons were observed to be most active during wakefulness ([@bib0205]).

***Function.*** Pharmacological studies indicate that GABAergic inputs to the DRN play a key role in REM induction ([@bib0365]; [@bib0870]). GABA concentrations in the DRN increase during REM sleep and pharmacological activation/inactivation of GABAa receptors increases and decreases REM sleep, respectively. GABAergic neurons in the vlPAG, DPGi and LPGi seem to provide the source of these GABAergic inputs.

While DRN DA neurons can induce arousal ([@bib0205]), the serotonergic effects on REM sleep are complex, depending on the expression and location of receptor subtypes ([@bib0830]): for example, 5-HT1A receptor expressing DRN 5-HT neurons inhibit adenylate cyclase. The administration of 5-HT1A agonists into the DRN reduces 5-HT concentration and enhances REM sleep ([@bib0955]). On the other hand, 5-HT1A receptor also expresses in downstream PPT/LDT cholinergic neurons. Microinjection of 5-HT1A receptor agonists into the LDT suppresses REM sleep ([@bib0840]). Thus, serotonergic effects on REM sleep are site-specific.

In summary, although it is widely thought that most serotonergic neurons are wake-promoting and REM-sleep-inhibiting, the exact roles of DRN neurons in sleep are still elusive. Because serotonin and sleep are closely related with depression, further studies on DRN neurons would be relevant from both basic scientific and clinical viewpoints.

2.2. Hypothalamic REM sleep-regulating circuits {#sec0050}
-----------------------------------------------

The hypothalamus consists of highly heterogeneous cell populations ([@bib1000]) and contributes to diverse biological functions including sleep related functions, such as the circadian rhythm, the stabilization of the sleep-wake cycle, and REM sleep regulation. In particular, a wide range of neuropeptides play a role in sleep regulation ([@bib1185]). Recent genetic-based circuit studies have significantly contributed to the advancement in this topic. In this section, we summarize the 1) molecular features, 2) anatomical features, 3) neural activity during REM sleep, and 4) gain- and loss-of-function studies, of three neuropeptidergic systems within the hypothalamus ([Fig. 2](#fig0010){ref-type="fig"}): orexin/hypocretin, melanin-concentrating hormone (MCH), and galanin.

### 2.2.1. Orexin/hypocretin {#sec0055}

Hypothalamic orexin/hypocretin (OH) neurons heavily innervate REM sleep-suppressing brainstem regions, including the LC, DRN, and vlPAG. A deficit in this system results in narcolepsy, with pathological intrusion of REM sleep, called cataplexy. Thus, this system is crucial for the physiological regulation of REM sleep by stabilizing wakefulness.

***Molecular features.*** OH is a neuropeptide, consisting of orexin A (hypocretin 1) and orexin B (hypocretin 2) derived from a common precursor peptide, prepro-orexin ([@bib0285]; [@bib1065]). OH can activate two G-protein-coupled receptors, OX1R and OX2R ([@bib1065]). The former has greater affinity for orexin A than orexin B whereas the latter has similar affinity for both types. OX1R is coupled to the Gq/11 to activate phospholipase C whereas OX2R is coupled to both Gq/11 and Gi.

***Anatomy.*** OH neurons are exclusively located in the lateral hypothalamus (LH) and posterior hypothalamus (PH). They coexpress dynorphin, galanin, prolactin, neuronal activity-regulated pentraxin and glutamate ([@bib0210]; [@bib0980]; [@bib0005]; [@bib1280]). Many OH neurons also express vesicular glutamate transporters, but not GAD67, suggesting that they are also glutamatergic ([@bib1010]).

OH neurons receive inputs from the lateral parabrachial nucleus, VLPO, medial and lateral preoptic areas, BF, posterior/dorsomedial hypothalamus, VTA, and median raphe nuclei ([@bib1070]; [@bib1435]). OH neurons also receive inputs from Lhx6-positive GABAergic neurons in the zona incerta (ZI) ([@bib0645]).

OH neurons widely project to various regions ([@bib0920]): in addition to innervating areas within the hypothalamus, the densest projection can be found in the LC. OH neurons also project to the septal nuclei, BNST, the paraventricular and reuniens nuclei of the thalamus, ZI, subthalamic nucleus, PGA (including vlPAG), substantia nigra, DRN, parabrachial area, PPT/LDT, medullary reticular formation, inferior colliculus, and the nucleus of the solitary tract. The expression pattern of OXRs is generally consistent with the innervation pattern of OH neurons. The distribution of OX1R and OX2R is partially overlapped, implying distinct functional roles ([@bib1270]; [@bib0740]; [@bib0670]).

***Activity.*** OH neurons are generally REM-off. They discharge during active wakefulness and decrease their firing during quiet wakefulness, but still respond to sensory stimulation. They are silent during sleep including both NREM and REM sleep ([@bib0435]; [@bib0625]; [@bib0815]).

***Function.*** Although OH neurons receive inputs from various wake-promoting neurons, their effects on OH neuronal activity are complex. For example, carbachol and histamine have excitatory effects on OH neurons ([@bib0165]; [@bib1070]) whereas serotonergic neurons have inhibitory effects ([@bib0855]; [@bib1070]). Effects of noradrenergic neurons are mixed ([@bib0190]; [@bib1425]; [@bib0425]). OH neurons are inhibited by a subset of GABAergic neurons (Lhx6+) in the ventral ZI to induce NREM sleep ([@bib0645]).

OH activates monoaminergic systems, including LC-NE, VTA-DA, DRN-5-HT, and histaminergic cells ([@bib1420]; [@bib0165]; [@bib0415]; [@bib0865]), consistent with the notion that OH plays a causal role in arousal ([@bib0015]). However, the effects of OH on cholinergic neurons depend on the cholinergic nucleus. For instance, orexin A injected into the LDT increases the time spent in wakefulness and decreases the time spent in REM sleep ([@bib1415]). Orexin A induces excitation of cholinergic neurons in the LDT ([@bib1220]) and BF ([@bib0320]). On the other hand, orexin A can indirectly inhibit PPT cholinergic neurons by activating PPT GABAergic interneurons as well as GABAergic neurons in the substantia nigra pars reticulata ([@bib1225]).

Effects of OH neuron activation on MCH neurons are generally inhibitory, but can also be excitatory ([@bib0050]; [@bib1315]; [@bib0435]). The inhibitory effect of OH cells on MCH neurons is probably due to the recruitment of local GABAergic neurons via OH activation, but not glutamatergic or dynorphinergic effects ([@bib0050]).

In summary, findings are generally consistent with the notion that OH neurons play a role in the stabilization of wakefulness by interacting with other wake/sleep-promoting neurons. However, detailed synaptic and circuit mechanisms remain to be fully characterized. In addition, although the OH system plays a causal role in narcolepsy ([@bib0940]; [@bib1060]; [@bib1250]; [@bib0925]; [@bib0640]; [@bib0195]; [@bib1280]), the cause of narcolepsy is still unclear.

### 2.2.2. Melanin-concentrating hormone {#sec0060}

While OH neurons stabilize wakefulness, melanin-concentrating hormone (MCH) neurons have the opposite effect on the regulation of sleep-wake states by increasing REM and NREM sleep.

***Molecular features.*** MCH was first discovered in fish ([@bib0565]; [@bib0965]) and later in the mammalian brain ([@bib1325]; [@bib0860]). MCH is produced from a preproprotein, called prepro-MCH, which also encodes neuropeptide-glutamic acid-isoleucine (NEI) and neuropeptide-glycine-glutamic acid (NGE). MCH is a 19-amino acid neuropeptide and binds to G-protein-coupled receptors, termed MCHR1 (or GPR24) and MCHR2. As MCHR1 is coupled with Gai/o and Gaq proteins, MCHR1 activation causes a strong inhibition of neurons ([@bib0440]). MCHR2 gene shows species differences: in rodents (the rat, mouse, hamster, and guinea pig) and rabbits, MCHR2 is a pseudogene, thus non-functional whereas in carnivores (the dog and ferret) and primate (rhesus macaque and human), MCHR2 is functional and expressed in the brain (such as the claustrum) ([@bib1235]). MCHR2 is coupled to Gq proteins, which trigger intraceullular signaling. However, the function of MCHR2 remains unknown.

***Anatomy.*** MCH neurons are primarily located in the LH and ZI. The distribution of MCH neurons shows sexually dimorphic patterns in rats. For example, MCH neurons can be found in the LDT of female but not male rats ([@bib1005]). Some MCH neurons co-express GAD67 and others express vGluT1 ([@bib0515]; [@bib0430]).

Anatomical inputs to MCH neurons has been characterized comprehensively ([@bib0380]). Of numerous brain regions, the following areas provide strong innervation to MCH neurons: the tuberal nucleus and the periventricular, the lateral, ventromedial and dorsomedial hypothalamic nuclei within the hypothalamus; the nucleus accumbens, BNST, and BF within the cerebral nuclei; and the midbrain reticular nucleus, PAG and VTA within the midbrain.

MCH neurons project to areas throughout the brain. In particular, they heavily innervate the LH, medial septum, medial diagonal band, lateral part of the medial mammillary nucleus, and PPT ([@bib0100]).

***Activity.*** A Fos mapping study demonstrated that MCH neurons are strongly active during REM sleep ([@bib1335]). This was subsequently confirmed with electrophysiology, whereby MCH neurons were observed to fire exclusively during REM sleep in rats ([@bib0435]). Thus, contrary to OH neurons, MCH neurons are REM-on.

***Function.*** Consistent with these observations, intracerebroventricular injection of MCH increases both NREM and REM sleep in a dose dependent manner ([@bib1335]). Similarly, when administered into the DRN, vlPAG and LC, MCH also increases the time spend in REM sleep, with a moderate increase in NREM when injected into the DRN ([@bib0610]; [@bib0355]; [@bib0845]). Furthermore, MCHR1 antagonist administration decreases REM and NREM sleep ([@bib0030]). However, an increase in REM sleep episodes was observed in MCHR1 knockout mice, suggesting that compensatory mechanisms are at play ([@bib0020]).

A series of optogenetic studies have shed new light on the function of MCH neurons ([@bib0585]; [@bib1285]; [@bib0515]). Although detailed approaches and optical stimulation protocols varied across reports, all three independent studies confirmed that the activation of MCH neurons increases the time spent in REM sleep. A chemogenetic study also confirmed a similar effect ([@bib1355]). On the other hand, varied optogenetic experimental parameters have also resulted in inconsistent effects being observed. For example, Jego and colleagues only observed increases in REM sleep duration with 20 Hz optical stimulation at the onset of REM sleep, but not with 1 Hz stimulation. Another recent study showed that optogenetic activation of MCH neurons increases both REM and NREM sleep at night (active period), but only increases REM sleep during the light period (inactive period) ([@bib0105]).

Optogenetic silencing of MCH neurons did not affect sleep architecture ([@bib1285]; [@bib0515]). Although genetic ablation of MCH neurons also had no effect on the total duration of REM sleep, the chronic deletion of MCH neurons altered the diurnal rhythm ([@bib1285]; [@bib1355]). Overall, MCH neurons play a regulatory role in REM sleep and probably NREM sleep too. However, given the activity pattern of MCH neurons across the sleep-wake cycle (∼ 1 Hz, not 20 Hz, during REM sleep), it is still unclear how MCH neurons modulate REM sleep-regulating circuits.

### 2.2.3. Galanin {#sec0065}

Galanin (GAL) is a neuropeptide expressed widely in the brain and peripheral tissue. While GAL has been implicated in the regulation of numerous physiological functions, GAL-positive (GAL+) neurons in the hypothalamus have been found to play a role in sleep regulation. However, the exact function of GAL + neurons in sleep remains uncertain. Here, we summarize the basic molecular and anatomical features of GAL and GAL receptors, and then focus on the function of hypothalamic GAL + neurons in REM sleep regulation.

***Molecular features.*** GAL consists of 29 amino acids ([@bib1240]) (30 amino acids in humans). GAL is produced from a 123-animo acid precursor, which is encoded by the *GAL* gene ([@bib0250]). Three G-protein-coupled GAL receptors have been identified: GALR1 and GALR3 inhibit adenylyl cyclase whereas GALR2 stimulates phospholipase C and increases intracellular inositol triphosphate turnover ([@bib0615]; [@bib0160]; [@bib1180]; [@bib0335]; [@bib0410]).

***Anatomy.*** GAL is widely expressed in the central nervous system, with strong expression in the hypothalamus, medulla, and spinal cord ([@bib0810]; [@bib1175]; [@bib0790]). In the telencephalon, GAL + neurons can be found in the BNST, BF, and central nucleus of amygdala. In the pons, the DRN and LC also contain a large number of GAL + neurons. GALRs are also widely expressed, but show distinct expression patterns ([@bib0805]; [@bib0580]; [@bib0875]; [@bib0895]), suggesting diverse functions of GAL.

Hypothalamic GAL + neurons are primarily GABAergic, but a recent study identified distinct sub-populations based on single-cell RNA sequencing analysis ([@bib1000]). Although beyond the scope of this review, a subset of cholinergic neurons in the BF also expresses GAL, implicating a role in arousal and memory ([@bib0820]; [@bib0785]).

***Activity and function.*** Although GAL administration does not promote REM sleep ([@bib1255]), GAL + neurons play a role in REM sleep regulation. Neurons extending dorsally and medially from the VLPO (called the extended VLPO, eVLPO) have been implicated in REM sleep regulation ([@bib0665]; [@bib0590]; [@bib1215]; [@bib0675]). Saper and his colleagues demonstrated that REM sleep duration is correlated with the number of Fos + neurons in the eVLPO - a majority of which are GAL-positive ([@bib0675]). eVLPO neurons project to both REM-on/-off regions, including the vlPAG, LDT, DRN and LC ([@bib0685], [@bib0675]). GAL inhibits LC neurons ([@bib1135]), suggesting REM sleep-promoting effects.

GAL + neurons in the dorsomedial hypothalamus (DMH) also regulate REM sleep ([@bib0200]). Interestingly, DMH GAL + neurons projecting to the preoptic area are REM-off and optogenetic activation of these neurons suppress REM sleep. The preoptic area also contains MCH neurons. On the other hand, DMH GAL + neurons projecting to the RPA in the vM are REM-on and optogenetic activation of these neurons promote REM sleep. Characterizing anatomical and functional interactions between two distinct GAL + neurons within the DMH would be interesting.

Thus, GAL + neurons can promote and inhibit REM sleep depending on implemented circuits. Further comprehensive anatomical and functional characterization will clarify the role of GAL + neurons in REM sleep. In addition, because GAL expression itself can be changed by responding to anatomical lesions or REM sleep deprivation ([@bib1255]; [@bib0240]), the dynamic regulatory mechanism of GAL expression is also an important issue.

3. Computational models of REM sleep {#sec0070}
====================================

The wake-sleep cycle is regulated by complex interactions between at least three fundamental processes: a homeostatic process, a circadian process, and an ultradian process. Computational models of sleep-wake cycles typically incorporate at least one of these processes. The main purpose of these computational models can be (1) to replicate the dynamics of sleep-wake cycles with and without perturbations, such as sleep deprivation and pharmacological manipulations, (2) to replicate the dynamics of neural population activity in sleep/wake regulating circuits, and (3) to explain the relationship between specific neural systems and disease states, such as the relationship between OH neurons and narcolepsy. The level of implementation varies across models, from the more conceptual model to the more detailed neural network models with varied architectures and formalizations. In this section, we provide a brief overview of the computational models of the sleep-wake cycle, with an emphasis on REM sleep. We begin by introducing Borbely's two-process model ([Fig. 3](#fig0015){ref-type="fig"}A) to provide a broad context of this topic. We will then focus on computational models of REM sleep regulation which include two major categories of models - the reciprocal interaction (RI) model and the mutual inhibition (MI) model (also known as the flip-flop switch model) ([Figs. 3](#fig0015){ref-type="fig"}**B and C**). Finally, we briefly summarize integrative models which contain various brain structures. Readers may also refer to other reviews ([@bib1365]; [@bib0135]; [@bib0120]).Fig. 3**Computational models of sleep-wake cycles and REM sleep.**(**A**) Two-process model (modified from Borbély 1982). Sleep is regulated by a homeostatic mechanism (Process S) and a circadian mechanism (Process C). Total sleep propensity is represented by the difference between the Processes S and C.(**B**) An elementary component of a Reciprocal Interaction (RI) model.(**C**) An elementary component of a Mutual Inhibition (MI) model. A homeostatic/circadian drive contribute to shifting states.(**D**) An example of an integrative model (modified from [@bib1230]). BS, brainstem; BF, basal forebrain; DR, dorsal raphe nucleus; LC, locus coeruleus; MnPN, median preoptic nucleus; PFH, perifornical hypothalamus; TMN, tuberomammillary nucleus; VLPO, ventrolateral preoptic area; 5 H T, serotonin; Ach, acetylcholine; GABA, gamma aminobutyric acid; HA, histamine; NA, noradrenaline; OH, orexin/hypocretin.Fig. 3

3.1. Two-process model {#sec0075}
----------------------

Borbely's two-process model offers a conceptual framework of sleep-wake cycles ([@bib0130]). In this model, a homeostatic sleep-dependent process (Process S) and a circadian process (Process C) play a dominant role in sleep regulation ([Fig. 3](#fig0015){ref-type="fig"}A). Process S reflects the global changes in cortical slow wave activity (SWA) as a biomarker. Process C can be explained by the activity of the suprachiasmatic nucleus (SCN) ([@bib1395]). Total sleep propensity is represented by the difference between the Processes S and C. After quantitative implementation of this concept ([@bib0260]), the two-process model was further extended with an external function to trigger REM sleep ([@bib0010]). Computational models over the last decade have implemented this model with detailed network architectures to reflect experimental observations. For example, Phillips and Robinson have implemented the two-process model in several neural network models which uses different neural population firing rate formalisms ([@bib0990]; [@bib0935], [@bib0930]). In the following sections, we focus on computational models of REM sleep regulation.

3.2. Reciprocal interaction model {#sec0080}
---------------------------------

The RI model consists of an excitatory REM-on population interacting with an inhibitory REM-off population ([Fig. 3](#fig0015){ref-type="fig"}B). The first of its kind was produced by McCarley and Hobson with REM-on neurons in the pontine cholinergic field interacting with REM-off neurons in the LC ([@bib0770]). A predator-prey interaction model with Lotka-Volterra equations was utilized in this model, whereby the activity of REM-off neurons (predator) gradually decays due to self-inhibition, which results in increased activity of REM-on neurons (prey). Although this model mimicked the time course of neural firing of REM-on and REM-off neurons, it was too sensitive to perturbations and did not include the circadian rhythm. Subsequently, the original model was extended by introducing a limit cycle as well as circadian variation ([@bib0775]). This limit cycle reciprocal interaction model (LCRIM) was applicable to human sleep data as well as for a simulation of pharmacological experiments. An integrated model was further developed to generate qualitatively realistic sleep-wave cycles by linking the two-process model with the LCRIM ([@bib0755]).

Recent models incorporated the dynamics of the RI model into a more physiologically based model ([@bib0125]; [@bib0085]; [@bib0305]; [@bib0090]; [@bib1230]), which we summarize in the section below. Although the original model was inspired by excitatory and inhibitory interactions between cholinergic and monoaminergic systems, experimental evidence (discussed above) over the last decade suggests that this reciprocal interaction may not be sufficient for REM sleep generation.

3.3. Mutual inhibition model {#sec0085}
----------------------------

The MI model (or flip-flop switch model) consists of mutual inhibitory interactions between REM-on and REM-off neurons ([Fig. 3](#fig0015){ref-type="fig"}C). The original model was conceptually proposed for wake-sleep regulation where sleep-promoting VLPO GABAergic neurons and wake-promoting monoaminergic neurons mutually inhibit each other. The wake stabilizing effects of OH neurons were also represented as a 'finger' of the flip-flop switch ([@bib1080]). Later, Lu and his colleagues extended this concept to REM-NREM regulation by experimentally demonstrating inhibitory REM-on and REM-off neurons within the brainstem ([@bib0685]). Since then, several computational models incorporated this mutual inhibition into their network architecture ([@bib0395]; [@bib0315]; [@bib0605]; [@bib0975]; [@bib0085]).

In this model, mutually inhibiting components provide a bistable feedback loop. Because a key feature of this circuit is self-reinforcing to stabilize a particular state, additional inputs to inhibitory components play a key role in shifting the balance of mutual inhibition, that is, state change. Such inputs can reflect circadian and/or homeostatic drives. However, the neural basis of such drives remains unknown.

Of recent models, Booth and her colleagues developed a simple, but elegant dynamical system model to implement this MI model with their neural population firing rate and neurotransmitter formalism ([@bib0315]). By coupling two flip-flop switches together, the model could capture rat sleep behavior including recovery after REM sleep deprivation.

Although most models have been developed as a population firing rate model with varied formalisms, a network model with leaky integrate-and-fire model neurons was also developed in order to assess the effect of muscarinic receptor anatagonism on REM-on subcoeruleus activity ([@bib0395]). In this model, MI between REM-on and --off neurons within the vlPAG was implemented with a ramping input to REM-off neurons. A similar network model with the large number of model neurons needs to be developed to fully capture the dynamics of sleep-wake cycles, not just the transition from NREM to REM sleep.

3.4. RI model versus MI model {#sec0090}
-----------------------------

What is the similarity and difference between the RI and MI models? How do each of these network motifs respond to perturbations? Which motif plays a primary causal role for REM sleep transitions? Although answers to these questions remain unclear, these issues were addressed by Diniz Behn and her colleagues ([@bib0095]). By using minimal RI and MI models with varied implementations of homeostatic drive, they identified conditions for the generation of REM-NREM sleep cycles and investigated the robustness of REM-NREM sleep cycles by analyzing the response of model dynamics to manipulation of synaptic interactions and self-modulatory inputs.

The RI model results in stable limit cycle oscillations rather than a single fixed point, meaning that continuous state shifts are inherited in this system. On the other hand, the MI model stabilizes the brain state. In contrast to the RI model, extrinsic inputs or parameter change are required to change the state within the MI model. Thus, the homeostatic drive plays a crucial role in REM-NREM sleep cycles in the MI model. These results suggest that the neuronal populations associated with the causal REM sleep network may be identified by evaluating distinct responses in REM sleep dynamics to experimental modulation of specific network components. The combination of experimental approaches with these types of computational studies will be helpful to interpret the dynamics of REM-on and REM-off neural firing as well as the effect of perturbations (e.g., optogenetics) on REM-NREM sleep cycles.

3.5. Integrative models {#sec0095}
-----------------------

While computational models for REM sleep can be conceptually categorized into two major categories, researchers have also developed integrative models that include various brain regions in accordance with experimental observations. For example, [@bib1230] developed an ambitious integrative model consisting of 10 subcortical nuclei across the BF, hypothalamus and brainstem, which can be categorized into four functional units: sleep-active, wake-active, REM-active (REM-on), and wake-REM-active groups ([Fig. 3](#fig0015){ref-type="fig"}D). Despite the large number of parameters, this 'quartet' network successfully reproduced the dynamics of neural firing in each component across sleep-wake cycles ([@bib1230]). Subsequently, different neural network models have been developed with varied network architectures and mathematical formalisms ([@bib0395]; [@bib0605]; [@bib0975]; [@bib0085]; [@bib0305]; [@bib0090]; [@bib0120]). As new experimental discoveries are made, such integrative models should be also updated. To date, at least two approaches are missing in this field: first, there are few computational models that implement the effects of optogenetic stimulation on REM sleep regulation ([@bib0190]). Second, a large-scale realistic network model with spiking model neurons has not been developed to the best of our knowledge.

4. Conclusion and future directions {#sec0100}
===================================

In summary, REM sleep-regulating circuits are widely distributed across the brainstem and hypothalamus, utilizing diverse neurotransmitters and neuropeptides. Thus, REM sleep-regulating circuits are a highly robust and complex system. While experimental findings are still fragmented and mostly qualitative, it is crucial to understand this complexity quantitatively by incorporating advanced technologies with computational modeling. In particular, computational models reflecting the latest experimental evidence are urgently required, together with quantifying anatomical/synaptic connections as well as characterizing the dynamics of neural ensembles in the hypothalamus and brainstem in a cell type-specific fashion.

To better understand REM sleep, at least five key questions remain to be addressed: the first issue is to determine the evolutionary origin of REM sleep. Given the complexity and redundancy of the regulatory circuit, it is not surprising that the primitive elements of REM sleep can be found in lower vertebrates ([@bib1140]). Although adult mice have been a popular choice as an animal model, further comparative ([@bib0520]) and developmental studies ([@bib0445]; [@bib0985]) will help shed new light on the mechanism underlying REM sleep regulation. Advanced anatomical methods, lineage tracing, and genome engineering may play an important role to this end.

The second issue is to dissect the anatomical complexity of REM sleep-regulating circuits at various levels. For example, what neurotransmitters and neuropeptides are utilized? How many cell types are contributing to REM sleep regulation? How are they anatomically connected in a cell-type-specific manner? Advanced genetic and single-cell profiling technologies, as well as the latest anatomical methods should be applied to address these questions ([@bib1370]). In addition, *in vitro* slice experiments will add quantitative information about synaptic connections.

The third issue is to determine the neural basis of homeostatic control of REM sleep. Although REM sleep deprivation has long been used for REM sleep experiments, the neural mechanisms underlying the homeostatic control of REM sleep remains elusive. A closed-loop experiment with optogenetic manipulations to manipulate the duration of REM sleep may be a promising approach to address this issue without causing stress compared to conventional approaches. This closed-loop approach will also offer an opportunity to explore the functions of REM sleep.

The forth issue is to decipher the dynamics of neural ensembles for REM sleep regulation. Since the identification of REM-on and --off neurons in 1970s, it is still unclear how these functionally distinct cell populations interact with each other. Monitoring neural ensembles across hypothalamic/brainstem areas and incorporating these findings with computational approaches will provide promising insights into the neural dynamics of REM sleep. Although realistic computational models with spiking neurons are also worth developing, quantitative descriptions of the electrophysiology and anatomy are still scarce. Efforts similar to those for cortical circuits are unmet needs in this field.

The final and most fundamental issue is to understand the function of REM sleep. Why did REM sleep emerge only in mammals, birds and some reptiles? Why does the duration of REM sleep decrease as the brain matures? What are the differences in memory-related neural processes between REM and NREM sleep? And why do we dream? Although several influential hypotheses have been proposed during the 1960s to 80s ([@bib0255]; [@bib0460]; [@bib0280]; [@bib0995]), they have not been fully tested experimentally. Accumulating evidence suggests the role of REM sleep in memory consolidation ([@bib0155]; [@bib1200]; [@bib0945]; [@bib1095]; [@bib0970]; [@bib1160]; [@bib0900]). While controversy surrounding this hypothesis has persisted, a recent study used optogenetics in mice to demonstrate that theta rhythm during REM sleep plays a causal role in spatial and contextual memory consolidation ([@bib0150]). Another recent imaging study showed that newly formed synapses of cortical layer 5 pyramidal cells can be selectively eliminated and maintained via dendritic calcium spike-dependent mechanisms during REM sleep ([@bib0635]). Thus, with the advent of recent revolutionary technologies, it is now an exciting period to revisit early hypotheses for a better understanding of REM sleep.
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ACh

:   acetylcholine

BF

:   basal forebrain

BNST

:   bed nucleus of the stria terminalis

DA

:   dopamine

DMH

:   dorsomedial hypothalamus

DpMe

:   deep mesencephalic reticular nucleus

DRN

:   dorsal raphe nucleus

EEG

:   electroencephalogram

eVLPO

:   extended area of the ventrolateral preoptic area

GABA

:   γ-aminobutyric acid

GiA

:   alpha gigantocellular nucleus

GiV

:   ventral gigantocellular nucleus

Glu

:   glutamate

Gly

:   glycine

LC

:   locus coeruleus

LDT

:   laterodorsal tegmental nucleus

LPB

:   lateral parabrachial nucleus

LPGi

:   lateral paragigantocellular nucleus

MCH

:   melanin-concentrating hormone

MPB

:   medial parabrachial nucleus

OH

:   orexin/hypocretin

PAG

:   periaqueductal gray

PPT

:   pedunculopontine tegmental nucleus

REM

:   rapid eye movement

RMg

:   raphe magnus

RPA

:   nucleus raphe pallidus

SLD

:   sublaterodorsal nucleus

vlPAG

:   ventrolateral periaqueductal gray

VLPO

:   ventrolateral preoptic area

vM

:   ventral medulla

vmM

:   ventromedial medulla

VTA

:   ventral tegmental area

ZI

:   zona incerta
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